- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Experimental Cancer Medicine Centres
Total 1966 results
-
Cardiff UniversityExperimental Cancer Medicine Centres; Leukaemia & Lymphoma Research GroupCompletedHigh Risk Myelodysplastic Syndrome | Acute Myeloid LeukaemiaUnited Kingdom
-
Experimental and Clinical Research CenterEnrolling by invitationGut Microbiota Dysbiosis and NutritionGermany
-
Imperial College LondonImperial College Healthcare NHS Trust; Experimental Cancer Medicine CentresRecruitingObesity | Prostate CancerUnited Kingdom
-
CCTU- Cancer ThemeCambridge University Hospitals NHS Foundation Trust; Cancer Research UK; Experimental...Active, not recruitingHigh Grade GliomaUnited Kingdom
-
University of BirminghamPfizer; AstraZeneca; Mirati Therapeutics Inc.; Cancer Research UK; Experimental Cancer...Active, not recruitingAdenocarcinoma | Carcinoma, Squamous Cell | Non-Small Cell Lung CancerUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterCenter for Experimental Therapeutics; F.M. KIRBY FOUNDATIONRecruitingLeptomeningeal MetastasesUnited States
-
Barts & The London NHS TrustCancer Research UK; UK: Barts Center for Experimental Cancer Medicine (CECM)...UnknownMalignant Pleural MesotheliomaUnited Kingdom
-
Centre of Experimental MedicineMillennium Pharmaceuticals, Inc.TerminatedProstate CancerUnited Kingdom
-
Abramson Cancer Center at Penn MedicineRecruiting
-
Abramson Cancer Center at Penn MedicineRecruitingGastrointestinal CancerUnited States
-
Abramson Cancer Center at Penn MedicineRecruitingBreast CancerUnited States
-
Abramson Cancer Center at Penn MedicineRecruitingNon-small Cell Lung CancerUnited States
-
Abramson Cancer Center at Penn MedicineRecruitingMelanoma | Melanoma Stage IIIUnited States
-
Abramson Cancer Center at Penn MedicineRecruitingEarly Stage Non-Small Cell Lung CancerUnited States
-
Abramson Cancer Center at Penn MedicineRecruitingSuspected Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerUnited States
-
Abramson Cancer Center at Penn MedicineRecruitingNo Restrictions on DiagnosisUnited States
-
Abramson Cancer Center at Penn MedicineActive, not recruiting
-
Abramson Cancer Center at Penn MedicineActive, not recruitingGastrointestinal CancerUnited States
-
Abramson Cancer Center at Penn MedicineCompletedMelanoma | Breast Cancer | Pancreatic Cancer | Metastatic | Non Small Cell Lung Cancer (NSCLC)United States
-
Abramson Cancer Center at Penn MedicineActive, not recruitingProstate AdenocarcinomaUnited States
-
Abramson Cancer Center at Penn MedicineCompletedOligometastatic Non-small Cell Lung Cancer (NSCLC)United States
-
Abramson Cancer Center at Penn MedicineActive, not recruiting
-
Abramson Cancer Center at Penn MedicineCompletedNon-small Cell Lung CancerUnited States
-
Abramson Cancer Center at Penn MedicineActive, not recruiting
-
Abramson Cancer Center at Penn MedicineActive, not recruitingEsophageal CancerUnited States
-
Abramson Cancer Center at Penn MedicineActive, not recruitingMeningioma | HemangiopericytomaUnited States
-
Abramson Cancer Center at Penn MedicineCompletedAdvanced Breast CancerUnited States
-
Abramson Cancer Center at Penn MedicineCompletedColorectal CancerUnited States
-
Abramson Cancer Center at Penn MedicineActive, not recruitingHeart Failure | Breast Cancer | Cardiomyopathies | Risk Factor, Cardiovascular | Cardiotoxicity | Toxicity Due to ChemotherapyUnited States
-
Abramson Cancer Center at Penn MedicineTerminatedPancreatic CancerUnited States
-
Abramson Cancer Center at Penn MedicineActive, not recruiting
-
Abramson Cancer Center at Penn MedicineActive, not recruiting
-
Abramson Cancer Center at Penn MedicineActive, not recruiting
-
Abramson Cancer Center at Penn MedicineActive, not recruitingProspective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic DiseasesNeoplastic DiseaseUnited States
-
Abramson Cancer Center at Penn MedicineActive, not recruiting
-
Abramson Cancer Center at Penn MedicineCompleted
-
Abramson Cancer Center at Penn MedicineNot yet recruitingMelanoma | Cardiotoxicity | Coronary Microvascular DysfunctionUnited States
-
Abramson Cancer Center at Penn MedicineRecruiting
-
Abramson Cancer Center at Penn MedicineRecruitingLung Cancer | Pulmonary Nodule, SolitaryUnited States
-
Abramson Cancer Center at Penn MedicineRecruitingSurvivorshipUnited States
-
Abramson Cancer Center at Penn MedicineRecruiting
-
Abramson Cancer Center at Penn MedicineRecruiting
-
Abramson Cancer Center at Penn MedicineRecruitingBreast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | ER Positive Breast CancerUnited States
-
Abramson Cancer Center at Penn MedicineRecruitingCancerUnited States
-
Abramson Cancer Center at Penn MedicineRecruiting
-
Abramson Cancer Center at Penn MedicineRecruitingBreast Cancer | Gastric Cancer | Cancer Gene MutationUnited States
-
Abramson Cancer Center at Penn MedicineRecruitingBreast DiseasesUnited States
-
Abramson Cancer Center at Penn MedicineRecruitingNon Hodgkin LymphomaUnited States
-
Abramson Cancer Center at Penn MedicineRecruiting
-
Abramson Cancer Center at Penn MedicineRecruiting